ATE65694T1 - Verwendung eines substituierten imidazols fuer die herstellung eines arzneimittels, verwendbar als sedativum oder analgetikum. - Google Patents

Verwendung eines substituierten imidazols fuer die herstellung eines arzneimittels, verwendbar als sedativum oder analgetikum.

Info

Publication number
ATE65694T1
ATE65694T1 AT85308748T AT85308748T ATE65694T1 AT E65694 T1 ATE65694 T1 AT E65694T1 AT 85308748 T AT85308748 T AT 85308748T AT 85308748 T AT85308748 T AT 85308748T AT E65694 T1 ATE65694 T1 AT E65694T1
Authority
AT
Austria
Prior art keywords
sedative
analgesic
medication
usable
manufacture
Prior art date
Application number
AT85308748T
Other languages
German (de)
English (en)
Inventor
Raimo Einari Virtanen
Arto Johannes Karjalainen
Kauko Oiva Antero Kurkela
Antti Tapani Vaha-Vahe
Outi Maritta Vainio-Kivinen
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Application granted granted Critical
Publication of ATE65694T1 publication Critical patent/ATE65694T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Stringed Musical Instruments (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT85308748T 1984-12-04 1985-12-02 Verwendung eines substituierten imidazols fuer die herstellung eines arzneimittels, verwendbar als sedativum oder analgetikum. ATE65694T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI844786A FI844786A0 (fi) 1984-12-04 1984-12-04 Terapeutiskt utnyttjbar foerening.
EP85308748A EP0187471B1 (en) 1984-12-04 1985-12-02 Use of a substituted imidazole for the manufacture of a medicament useful as a sedative or analgesic

Publications (1)

Publication Number Publication Date
ATE65694T1 true ATE65694T1 (de) 1991-08-15

Family

ID=8520010

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85308748T ATE65694T1 (de) 1984-12-04 1985-12-02 Verwendung eines substituierten imidazols fuer die herstellung eines arzneimittels, verwendbar als sedativum oder analgetikum.

Country Status (11)

Country Link
US (1) US4670455A (OSRAM)
EP (1) EP0187471B1 (OSRAM)
JP (1) JPS61134314A (OSRAM)
AT (1) ATE65694T1 (OSRAM)
AU (1) AU572364B2 (OSRAM)
DE (1) DE3583670D1 (OSRAM)
DK (1) DK163960C (OSRAM)
FI (1) FI844786A0 (OSRAM)
IE (1) IE58269B1 (OSRAM)
NZ (1) NZ213604A (OSRAM)
ZA (1) ZA858416B (OSRAM)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI864570A0 (fi) * 1986-11-11 1986-11-11 Farmos Oy Terapeutiskt anvaendbar foerening.
GB2206880B (en) 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative
GB2215206B (en) 1988-02-29 1991-07-03 Farmos Oy 4-substituted imidazole derivatives useful in perioperative care
US5344840A (en) * 1988-02-29 1994-09-06 Orion-Yhtyma Oy 4-substituted imidazole derivatives useful in perioperative care
US5124157A (en) 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
AR015744A1 (es) * 1998-04-01 2001-05-16 Orion Corp Uso de dexmedetomidina para sedacion en terapia intensiva
FI20041425A0 (fi) * 2004-11-05 2004-11-05 Orion Corp Transmukosaalinen veterinäärinen koostumus
US7795263B2 (en) * 2008-07-08 2010-09-14 Wildlife Laboratories, Inc. Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals
EP2370136A4 (en) * 2008-12-01 2015-12-30 Map Pharmaceuticals Inc INHALATIVE RELEASE PROCEDURES AND DEVICES
US8555875B2 (en) * 2008-12-23 2013-10-15 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
US20130096170A1 (en) 2011-10-14 2013-04-18 Hospira, Inc. Methods of treating pediatric patients using dexmedetomidine
WO2013069025A1 (en) 2011-11-11 2013-05-16 Neon Laboratories Ltd. "process for the preparation of dexmedetomidine"
US8242158B1 (en) 2012-01-04 2012-08-14 Hospira, Inc. Dexmedetomidine premix formulation
RU2658463C2 (ru) 2013-10-07 2018-06-21 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Способы и композиции для лечения синдрома дефицита внимания и гиперактивности, тревожности и бессонницы с применением трансдермальных композиций на основе дексмедетомидина
ES2847936T3 (es) 2013-10-07 2021-08-04 Teikoku Pharma Usa Inc Métodos y composiciones para el suministro transdérmico de una cantidad no sedante de dexmedetomidina
KR101827980B1 (ko) 2013-10-07 2018-02-13 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 전달 장치 및 이의 사용 방법
US9717796B1 (en) 2016-04-20 2017-08-01 Slypharma, Llc Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container
DK3562486T3 (da) 2016-12-31 2024-06-10 Bioxcel Therapeutics Inc Anvendelse af sublingual dexmedetomidin til behandling af agitation
PL3813802T3 (pl) 2018-06-27 2025-04-22 Bioxcel Therapeutics, Inc. Formulacje błony zawierające deksmedetomidynę i sposoby ich wytwarzania
US11160791B2 (en) 2018-11-01 2021-11-02 Medefil, Inc. Dexmedetomidine injection premix formulation in ready to use (RTU) bags
KR20220049526A (ko) 2019-07-19 2022-04-21 바이오엑셀 테라퓨틱스 인코포레이티드 비-진정성 덱스메데토미딘 치료 양생법
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2092569B (en) * 1981-02-05 1984-09-19 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB2096987B (en) * 1981-04-22 1984-04-04 Farmos Oy Substituted imidazole and imidazole derivatives and their preparation and use
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
CA1212115A (en) * 1982-08-14 1986-09-30 Peter B. Thorogood Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations

Also Published As

Publication number Publication date
DK163960C (da) 1992-09-21
DE3583670D1 (de) 1991-09-05
EP0187471B1 (en) 1991-07-31
EP0187471A3 (en) 1988-09-14
JPH0465050B2 (OSRAM) 1992-10-16
FI844786A0 (fi) 1984-12-04
DK508985A (da) 1986-06-05
DK508985D0 (da) 1985-11-05
IE58269B1 (en) 1993-08-25
JPS61134314A (ja) 1986-06-21
DK163960B (da) 1992-04-27
NZ213604A (en) 1988-09-29
IE853024L (en) 1986-06-04
US4670455A (en) 1987-06-02
AU4997185A (en) 1986-06-12
EP0187471A2 (en) 1986-07-16
AU572364B2 (en) 1988-05-05
ZA858416B (en) 1986-07-30

Similar Documents

Publication Publication Date Title
ATE65694T1 (de) Verwendung eines substituierten imidazols fuer die herstellung eines arzneimittels, verwendbar als sedativum oder analgetikum.
YU174490A (sh) Novi estri tienil-karboksilne kiseline sa aminoalkoholima, njihova kvaterna jedinjenja kao i pripremanje i primena tih jedinjenja
YU47204B (sh) Derivati didehidro-vitamina d3
PT83647B (pt) Processo para a preparacao de novos derivados de benzimidazole com actividade farmacologica e de composicoes farmaceuticas que os contem
NO2013002I1 (no) Aklidinium haogenid (Aklidinium bromid)
NO970067L (no) Nytt farmasöytisk preparat for smertebehandling
NL182936C (nl) Anti-inflammatoire en analgetische zalf, die indomethacine als actieve component bevat.
AU3027289A (en) 4-substituted imidazole derivatives useful in perioperative care
ATE53377T1 (de) 1-substituierte tetralinderivate, ihre herstellung und verwendung.
NO911233D0 (no) Nye retinoider.
KR840006230A (ko) 1-페닐-2-메틸-3-(1-피로리디닐)-1-프로판온 유도체의 제조방법
ES2125574T3 (es) Procedimiento para la preparacion de (-)-n-metil-n-(4-(4-fenil-4-acetilaminopiperidin-1-il)-2-(3,4-diclorofenil)butil)-benzamida y sus sales farmaceuticamente aceptables.
FI880987A0 (fi) 1-(1-aryl-2-hydroxietyl) imidazoler och deras salter, foerfarande foer deras framstaellning, laekemedel innehaollande dessa foereningar och deras anvaendning.
IT1211092B (it) Dieteri dell'alcool 4-idrossi-benzi lico
MX9300763A (es) Imidazoles sustituidos por sulfonilbencilo, procedimiento para su obtencion, medicamentos que los contienen y procedimiento para la obtencion de tales medicamentos
ES2039273T3 (es) Compuestos antimicoticos a base de combinaciones de nicomicina y azol antimicotico.
SE8503443D0 (sv) New azole, process for its production and its use
ATE2839T1 (de) 1-(3'-benzofuryl)-4-benzylpiperazin enthaltendes schmerzstillendes arzneimittel und verfahren zu seiner herstellung.
ATE71835T1 (de) Verwendung von 2-((2-brom-6fluorphenyl)imino>imidazolidin als sedativum.
DE3874361D1 (de) Als analgetika verwendbare 1-((4-morpholinyl)alkyl)-1h-indole und deren herstellung.
ES2078976T3 (es) Dosificador que comprende un tonoforo.
FI822552L (fi) Insektlockaemne
SU820186A1 (ru) 1-[4-(3',4'-диоксифенил)-тиазолил-2]-3-алкил-5-тетрафторэтилпиразолы, обладающие акарицидной активностью
MX9302644A (es) Nuevos enantiomeros derivados de (s)-2-amino-2-(3-4-diclorobencil)-1-propanol-
ECSP961643A (es) '2-(2-n-alcoxifenil-)-purin-6 onas- 9 sustituidas lea 30701- ec

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time